Development of New Proliferative Diabetic Retinopathy in the BEVORDEX Trial

Ophthalmol Retina. 2019 Mar;3(3):286-287. doi: 10.1016/j.oret.2018.10.010. Epub 2018 Oct 25.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Anti-Inflammatory Agents / therapeutic use*
  • Bevacizumab / therapeutic use*
  • Dexamethasone / therapeutic use*
  • Diabetic Retinopathy / drug therapy*
  • Humans
  • Kaplan-Meier Estimate
  • Macular Edema / drug therapy*
  • Proportional Hazards Models

Substances

  • Angiogenesis Inhibitors
  • Anti-Inflammatory Agents
  • Bevacizumab
  • Dexamethasone